中华病理学杂志
中華病理學雜誌
중화병이학잡지
Chinese Journal of Pathology
2014年
6期
383-388
,共6页
陈燕%肖立%朱雄增%卢晨%余波%范德生%殷于磊
陳燕%肖立%硃雄增%盧晨%餘波%範德生%慇于磊
진연%초립%주웅증%로신%여파%범덕생%은우뢰
淋巴瘤,大B-细胞,弥漫性%免疫表型分型%预后%病理学,临床
淋巴瘤,大B-細胞,瀰漫性%免疫錶型分型%預後%病理學,臨床
림파류,대B-세포,미만성%면역표형분형%예후%병이학,림상
Lymphoma,large B-cell diffuse%Immunophenotyping%Prognosis%Pathology,clinical
目的 探讨弥漫性大B细胞淋巴瘤(diffuse large B-cell lymphoma,DLBCL)的免疫学分型与预后的关系.方法 用Hans、Choi和Tally三种免疫学分型法则对148例华东地区DLBCL病例进行免疫学分型,比较三种法则的免疫学分型结果与临床特征及生存资料的关系,并用Cox比例风险回归模型对本组病例进行临床特征及免疫学分型等多因素生存分析.结果 148例DLBCL三种法则分型结果得到的生发中心B细胞样(germinal center B-cell-like,GCB)亚型显著低于非GCB(non-GCB)/活化B细胞样(activated B-cell-like,ABC)亚型(P<0.05),其中Tally法则得到的GCB亚型数最低.三种法则分型结果完全一致的病例114例(77.0%),其中GCB亚型(19例,16.7%)亦显著低于非GCB/ABC亚型(95例,83.3%;P=0.000 1).80例有随访资料的病例三种分型法则所得到的GCB和非GCB/ABC亚型的5年总体生存(overall survival,OS)率及生存曲线均无明显差异(P>0.05).三种法则分型结果均显示原发于胃的DLBCL(primary gastric DLBCL,PG-DLBCL)的GCB亚型数倾向高于其他组别,PG-DLBCL的5年OS率及生存曲线也倾向好于其他组别.Cox多因素生存模型分析发现,年龄(HR=1.036,P=0.001)及分期(HR=1.997,P=0.000)对患者生存期有显著影响,年龄越大及分期越高患者死亡风险增加,然而三种法则分型结果均对患者生存期无明显影响.结论 Hans、Choi和Tally三种免疫学分型法则均不能有效地对华东地区DLBCL进行预后相关分组.PG-DLBCL的免疫表型及临床预后可能不同于其他部位DLBCL.
目的 探討瀰漫性大B細胞淋巴瘤(diffuse large B-cell lymphoma,DLBCL)的免疫學分型與預後的關繫.方法 用Hans、Choi和Tally三種免疫學分型法則對148例華東地區DLBCL病例進行免疫學分型,比較三種法則的免疫學分型結果與臨床特徵及生存資料的關繫,併用Cox比例風險迴歸模型對本組病例進行臨床特徵及免疫學分型等多因素生存分析.結果 148例DLBCL三種法則分型結果得到的生髮中心B細胞樣(germinal center B-cell-like,GCB)亞型顯著低于非GCB(non-GCB)/活化B細胞樣(activated B-cell-like,ABC)亞型(P<0.05),其中Tally法則得到的GCB亞型數最低.三種法則分型結果完全一緻的病例114例(77.0%),其中GCB亞型(19例,16.7%)亦顯著低于非GCB/ABC亞型(95例,83.3%;P=0.000 1).80例有隨訪資料的病例三種分型法則所得到的GCB和非GCB/ABC亞型的5年總體生存(overall survival,OS)率及生存麯線均無明顯差異(P>0.05).三種法則分型結果均顯示原髮于胃的DLBCL(primary gastric DLBCL,PG-DLBCL)的GCB亞型數傾嚮高于其他組彆,PG-DLBCL的5年OS率及生存麯線也傾嚮好于其他組彆.Cox多因素生存模型分析髮現,年齡(HR=1.036,P=0.001)及分期(HR=1.997,P=0.000)對患者生存期有顯著影響,年齡越大及分期越高患者死亡風險增加,然而三種法則分型結果均對患者生存期無明顯影響.結論 Hans、Choi和Tally三種免疫學分型法則均不能有效地對華東地區DLBCL進行預後相關分組.PG-DLBCL的免疫錶型及臨床預後可能不同于其他部位DLBCL.
목적 탐토미만성대B세포림파류(diffuse large B-cell lymphoma,DLBCL)적면역학분형여예후적관계.방법 용Hans、Choi화Tally삼충면역학분형법칙대148례화동지구DLBCL병례진행면역학분형,비교삼충법칙적면역학분형결과여림상특정급생존자료적관계,병용Cox비례풍험회귀모형대본조병례진행림상특정급면역학분형등다인소생존분석.결과 148례DLBCL삼충법칙분형결과득도적생발중심B세포양(germinal center B-cell-like,GCB)아형현저저우비GCB(non-GCB)/활화B세포양(activated B-cell-like,ABC)아형(P<0.05),기중Tally법칙득도적GCB아형수최저.삼충법칙분형결과완전일치적병례114례(77.0%),기중GCB아형(19례,16.7%)역현저저우비GCB/ABC아형(95례,83.3%;P=0.000 1).80례유수방자료적병례삼충분형법칙소득도적GCB화비GCB/ABC아형적5년총체생존(overall survival,OS)솔급생존곡선균무명현차이(P>0.05).삼충법칙분형결과균현시원발우위적DLBCL(primary gastric DLBCL,PG-DLBCL)적GCB아형수경향고우기타조별,PG-DLBCL적5년OS솔급생존곡선야경향호우기타조별.Cox다인소생존모형분석발현,년령(HR=1.036,P=0.001)급분기(HR=1.997,P=0.000)대환자생존기유현저영향,년령월대급분기월고환자사망풍험증가,연이삼충법칙분형결과균대환자생존기무명현영향.결론 Hans、Choi화Tally삼충면역학분형법칙균불능유효지대화동지구DLBCL진행예후상관분조.PG-DLBCL적면역표형급림상예후가능불동우기타부위DLBCL.
Objective To study the immunohistochemical classification and prognosis of diffuse large B-cell lymphoma (DLBCL).Methods A total of 148 cases of DLBCL were classified into germinal center B-cell-like (GCB) and non-GCB/activated B-cell-like (ABC) subtypes by Hans,Choi and Tally immunohistochemical stain algorithms.The clinical features and survival data of GCB and non-GCB/ABC subtypes were compared.Multivariate analysis about clinical features and results of immunohistochemical stain algorithms was carried out by using Cox regression,with overall survival as the outcome.Results The prevalence of GCB subtype was significantly lower than that of non-GCB/ABC subtype,as classified by whichever algorithms in the 148 DLBCL cases studied.The prevalence of GCB subtype by Tally algorithm was lowest.The prevalence of GCB subtype (19 cases,16.7%) was also significantly lower than non-GCB/ ABC subtype (95 cases,83.3% ; P =0.000 1) in the 114 (77.0%) concordant cases by the three algorithms.There was no difference between GCB and non-GCB/ABC subtypes by the three algorithms in five-year overall survival rate and survival curve of the 80 DLBCL patients with follow-up data available (P > 0.05).Primary gastric DLBCL tended to show a higher prevalence of GCB subtype,a better five-year overall survival rate and survival curve than the other groups.Multivariate analysis showed that patient age (HR=1.036,P =0.001) and tumor stage (HR =1.997,P =0) were also significantly adverse predictors of overall survival.Conclusion The Hans,Choi and Tally immunohistochemical stain algorithms cannot effectively classify Chinese DLBCL into different prognostic subtypes.Primary gastric DLBCL has different immunophenotype and outcome,as compared with DLCBL in other sites.